Cyfuse Biomedical K.K. (TYO:4892)

Cyfuse Biomedical K.K. Statistics

Total Valuation

TYO:4892 has a market cap or net worth of JPY 5.41 billion. The enterprise value is 2.91 billion.

Market Cap	5.41B
Enterprise Value	2.91B

Important Dates

The next estimated earnings date is Friday, February 13, 2026.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

TYO:4892 has 8.30 million shares outstanding. The number of shares has increased by 5.78% in one year.

Current Share Class	8.30M
Shares Outstanding	8.30M
Shares Change (YoY)	+5.78%
Shares Change (QoQ)	+10.01%
Owned by Insiders (%)	13.43%
Owned by Institutions (%)	7.28%
Float	4.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	60.75
PB Ratio	1.89
P/TBV Ratio	1.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.44
EV / Sales	32.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.89, with a Debt / Equity ratio of 0.44.

Current Ratio	5.89
Quick Ratio	5.64
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-75.92

Financial Efficiency

Return on equity (ROE) is -30.28% and return on invested capital (ROIC) is -241.01%.

Return on Equity (ROE)	-30.28%
Return on Assets (ROA)	-14.31%
Return on Invested Capital (ROIC)	-241.01%
Return on Capital Employed (ROCE)	-25.10%
Revenue Per Employee	4.24M
Profits Per Employee	-40.24M
Employee Count	21
Asset Turnover	0.02
Inventory Turnover	0.98

Taxes

In the past 12 months, TYO:4892 has paid 2.00 million in taxes.

Income Tax	2.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.17% in the last 52 weeks. The beta is 1.52, so TYO:4892's price volatility has been higher than the market average.

Beta (5Y)	1.52
52-Week Price Change	+43.17%
50-Day Moving Average	588.86
200-Day Moving Average	722.38
Relative Strength Index (RSI)	58.78
Average Volume (20 Days)	251,795

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYO:4892 had revenue of JPY 89.00 million and -845.00 million in losses. Loss per share was -100.20.

Revenue	89.00M
Gross Profit	35.00M
Operating Income	-911.00M
Pretax Income	-843.00M
Net Income	-845.00M
EBITDA	-874.50M
EBIT	-911.00M
Loss Per Share	-100.20

Balance Sheet

The company has 3.74 billion in cash and 1.25 billion in debt, with a net cash position of 2.50 billion or 300.67 per share.

Cash & Cash Equivalents	3.74B
Total Debt	1.25B
Net Cash	2.50B
Net Cash Per Share	300.67
Equity (Book Value)	2.86B
Book Value Per Share	313.29
Working Capital	3.28B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	39.33%
Operating Margin	-1,023.60%
Pretax Margin	-947.19%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TYO:4892 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.78%
Shareholder Yield	-5.78%
Earnings Yield	-15.63%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TYO:4892 has an Altman Z-Score of 1.57 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.57
Piotroski F-Score	2